Expedition raises $115m Series B to advance COPD drug EXPD-101, with support from General Atlantic and other investors, strengthening their regulatory and operational capabilities.
Amount Raised
$115 Million
Round Type
Series B
Investors
Description
Expedition has successfully raised $115 million in Series B financing to progress its EXPD-101 drug for chronic obstructive pulmonary disease (COPD). The funds will be utilized to enhance clinical, regulatory, and operational capabilities while expanding their pipeline. The company aims to generate high-quality clinical data to improve treatment options for COPD patients. This round attracted a strong syndicate of investors who align with Expedition's long-term vision.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Expedition that raised within 45 days of this round, from Fundz verified event records.
- Big Picture Bio raised $2M (Pre-Seed) on September 18, 2026.
- Navigator Medicines raised $10M on September 18, 2026.
- Matisse Pharmaceuticals B.V raised $16M (Series A) on September 17, 2026.
- Lisata Therapeutics raised $352M (Series C) on September 17, 2026.
- Amani Therapeutics raised $35M on September 16, 2026.
- Aitiologic raised $7.4M (Seed) on September 15, 2026.
Who to call at Expedition, and when
A new round usually means Expedition is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Expedition raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Expedition, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Expedition. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Expedition raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansExpedition raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.